iSpecimen Inc. (ISPC) Misses Q2 EPS by 9c

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.39), $0.09 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.63 million versus the consensus estimate of $3.07 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• SDCH (SDCH) Reports Q2 Loss of $0.03
• Ascend Wellness Holdings, Inc. (AAWH) Tops Q2 EPS by 3c